These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 15796957)

  • 21. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.
    Jones TD; Eble JN; Wang M; MacLennan GT; Delahunt B; Brunelli M; Martignoni G; Lopez-Beltran A; Bonsib SM; Ulbright TM; Zhang S; Nigro K; Cheng L
    Clin Cancer Res; 2005 Oct; 11(20):7226-33. PubMed ID: 16243792
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chromosomal abnormalities in renal cell neoplasms associated with acquired renal cystic disease. A series studied by comparative genomic hybridization and fluorescence in situ hybridization.
    Gronwald J; Baur AS; Holtgreve-Grez H; Jauch A; Mosimann F; Jichlinski P; Wauters JP; Cremer T; Guillou L
    J Pathol; 1999 Feb; 187(3):308-12. PubMed ID: 10398084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renal cell carcinomas with papillary architecture and clear cell components: the utility of immunohistochemical and cytogenetical analyses in differential diagnosis.
    Gobbo S; Eble JN; Maclennan GT; Grignon DJ; Shah RB; Zhang S; Martignoni G; Brunelli M; Cheng L
    Am J Surg Pathol; 2008 Dec; 32(12):1780-6. PubMed ID: 18779729
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pediatric renal carcinoma associated with Xp11.2 translocations/TFE3 gene fusions and clinicopathologic associations.
    Altinok G; Kattar MM; Mohamed A; Poulik J; Grignon D; Rabah R
    Pediatr Dev Pathol; 2005; 8(2):168-80. PubMed ID: 15747097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chromosome 1 analysis in chromophobe renal cell carcinomas with tissue microarray (TMA)-facilitated fluorescence in situ hybridization (FISH) demonstrates loss of 1p/1 which is also present in renal oncocytomas.
    Meyer PN; Cao Y; Jacobson K; Krausz T; Flanigan RC; Picken MM
    Diagn Mol Pathol; 2008 Sep; 17(3):141-4. PubMed ID: 18382368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A combination of molecular cytogenetic analyses reveals complex genetic alterations in conventional renal cell carcinoma.
    Strefford JC; Stasevich I; Lane TM; Lu YJ; Oliver T; Young BD
    Cancer Genet Cytogenet; 2005 May; 159(1):1-9. PubMed ID: 15860350
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytogenetic and morphologic typing of 58 papillary renal cell carcinomas: evidence for a cytogenetic evolution of type 2 from type 1 tumors.
    Gunawan B; von Heydebreck A; Fritsch T; Huber W; Ringert RH; Jakse G; Füzesi L
    Cancer Res; 2003 Oct; 63(19):6200-5. PubMed ID: 14559804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chromosomal abnormalities of clear cell renal cell carcinoma: frequent gain of chromosome 7.
    Kuroda N; Tamura M; Shiotsu T; Nakamura S; Taguchi T; Tominaga A; Hes O; Michal M; Kawada C; Shuin T; Lee GH
    Pathol Int; 2010 Jan; 60(1):9-13. PubMed ID: 20055946
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differentiation of multifocal renal cell carcinoma by comparative genomic hybridization.
    Junker K; Hindermann W; Schubert J; Schlichter A
    Anticancer Res; 1999; 19(2C):1487-92. PubMed ID: 10365129
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of chromosomes in clear cell renal cell carcinoma and in corresponding renal parenchyma.
    Feil G; Leipoldt M; Nelde HJ; Wunderer A; Wechsel HW; Kaiser P; Bichler KH
    Anticancer Res; 1999; 19(2C):1477-82. PubMed ID: 10365127
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular cytogenetic characterization shows higher genetic homogeneity in conventional renal cell carcinoma compared to other kidney cancers.
    Alimov A; Sundelin B; Bergerheim U; Pavlenko M; Pisa P; Zetterberg A; Larsson C; Lagercrantz S
    Int J Oncol; 2004 Oct; 25(4):955-60. PubMed ID: 15375545
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clear cell papillary renal cell carcinoma: a distinct histopathologic and molecular genetic entity.
    Gobbo S; Eble JN; Grignon DJ; Martignoni G; MacLennan GT; Shah RB; Zhang S; Brunelli M; Cheng L
    Am J Surg Pathol; 2008 Aug; 32(8):1239-45. PubMed ID: 18594469
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dissecting karyotypic patterns in renal cell carcinoma: an analysis of the accumulated cytogenetic data.
    Höglund M; Gisselsson D; Soller M; Hansen GB; Elfving P; Mitelman F
    Cancer Genet Cytogenet; 2004 Aug; 153(1):1-9. PubMed ID: 15325087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Xp11 translocation renal cell carcinoma in adults: expanded clinical, pathologic, and genetic spectrum.
    Argani P; Olgac S; Tickoo SK; Goldfischer M; Moch H; Chan DY; Eble JN; Bonsib SM; Jimeno M; Lloreta J; Billis A; Hicks J; De Marzo AM; Reuter VE; Ladanyi M
    Am J Surg Pathol; 2007 Aug; 31(8):1149-60. PubMed ID: 17667536
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytogenetic analysis of three primary Bellini duct carcinomas.
    Gregori-Romero MA; Morell-Quadreny L; Llombart-Bosch A
    Genes Chromosomes Cancer; 1996 Mar; 15(3):170-2. PubMed ID: 8721681
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence for polyclonal origin of multifocal clear cell renal cell carcinoma.
    Cheng L; MacLennan GT; Zhang S; Wang M; Zhou M; Tan PH; Foster S; Lopez-Beltran A; Montironi R
    Clin Cancer Res; 2008 Dec; 14(24):8087-93. PubMed ID: 19088024
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Validation of a TFE3 break-apart FISH assay for Xp11.2 translocation renal cell carcinomas.
    Mosquera JM; Dal Cin P; Mertz KD; Perner S; Davis IJ; Fisher DE; Rubin MA; Hirsch MS
    Diagn Mol Pathol; 2011 Sep; 20(3):129-37. PubMed ID: 21817901
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renal cancer: cytogenetic and molecular genetic aspects.
    Meloni-Ehrig AM
    Am J Med Genet; 2002 Oct; 115(3):164-72. PubMed ID: 12407697
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigation of bone marrow involvement in malignant lymphoma using fluorescence in situ hybridization: possible utility in the detection of micrometastasis.
    Huh HJ; Min HC; Cho HI; Chae SL; Lee DS
    Cancer Genet Cytogenet; 2008 Oct; 186(1):1-5. PubMed ID: 18786435
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The application of cytogenetics and fluorescence in situ hybridization to fine-needle aspiration in the diagnosis and subclassification of renal neoplasms.
    Roh MH; Dal Cin P; Silverman SG; Cibas ES
    Cancer Cytopathol; 2010 Jun; 118(3):137-45. PubMed ID: 20544709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.